Position
Chief Medical Officer
Company
Zentalis Pharmaceuticals
Description
Zentalis Pharmaceuticals is making changes to its executive team, with the appointment of a new CEO and chief medical officer. Julie Eastland, former CEO of Merck-acquired Harpoon Therapeutics, will take over as CEO, while experienced oncology executive Ingmar Bruns, M.D., Ph.D., has been selected as the new chief medical officer.
Quick answer
Zentalis Pharmaceuticals Appoints New CEO and Chief Medical Officer (November 15, 2024). Zentalis Pharmaceuticals is based in San Diego, California, United States.
- What did Zentalis Pharmaceuticals announce on November 15, 2024?
- Zentalis Pharmaceuticals is making changes to its executive team, with the appointment of a new CEO and chief medical officer. Julie Eastland, former CEO of Merck-acquired Harpoon Therapeutics, will take over as CEO, while experienced oncology executive Ingmar Bruns, M.D., Ph.D., has been selected as the new chief medical officer.
- What does Zentalis Pharmaceuticals do?
- Zentalis® Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1+ platinum-resistant...
- Where is Zentalis Pharmaceuticals based?
- Zentalis Pharmaceuticals is based in San Diego, California, United States.
- Which similar companies made leadership changes around the same time?
- NRx Pharmaceuticals (November 18, 2024), Faeth Therapeutics (November 22, 2024), Azora Therapeutics, Inc. (DE) (November 5, 2024) and ALX Oncology (November 14, 2024) also announced leadership changes within 45 days of Zentalis Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Medical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- NRx Pharmaceuticals Appoints Michael Abrams as Chief Financial Officer (November 18, 2024)
- Faeth Therapeutics Appoints Dr. Stephen Hahn as Chief Medical Executive and Dr. Jayson Dallas as Chief Executive Officer (November 22, 2024)
- Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer (November 5, 2024)
- ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer (November 14, 2024)
- Greywolf Therapeutics Appoints Darlene Deptula-Hicks as Chief Financial Officer (November 14, 2024)
- Diakonos Oncology Appoints Laura Aguilar, M.D., Ph.D. as Chief Medical Officer (November 18, 2024)
Who to call at Zentalis Pharmaceuticals, and when
A new leader at Zentalis Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Zentalis Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Zentalis Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Zentalis Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Zentalis Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Zentalis Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.